A tripeptide and a pentadecapeptide
KPV is the tripeptide lysine-proline-valine, the three C-terminal residues of alpha-melanocyte-stimulating hormone. BPC-157 is a synthetic chain of fifteen residues whose sequence comes from a larger protein first described in gastric juice; it is covered residue by residue in BPC-157: peptide identity, purity, and stability. The figures below are the ones published on the KPV 10mg and BPC-157 10mg listings, with the expected ions calculated from those formulas.
| Property | KPV | BPC-157 |
|---|---|---|
| Sequence | Lys-Pro-Val (KPV) | GEPPPGKPADDAGLV |
| Residue count | 3 | 15 |
| Termini | Free amine, free acid | Free amine, free acid |
| Molecular formula | C16H30N4O4 | C62H98N16O22 |
| CAS registry number | 67727-97-3 | 137525-51-0 |
| Theoretical average mass | 342.4 g/mol | 1,419.5 g/mol |
| Theoretical monoisotopic mass | approximately 342.2 | approximately 1,418.7 |
| Expected singly charged ion [M+H]+ | near m/z 343.2 | near m/z 1,419.7 |
| Expected doubly charged ion [M+2H]2+ | near m/z 172.1 | near m/z 710.4 |
| Sulfur in the formula | None | None |
| Aromatic residues | None | None |
| Physical form supplied | Lyophilized solid | Lyophilized solid |
An N-acetylated, C-amidated form of KPV also appears in the literature. It has the formula C18H33N5O4 and sits about 41 units heavier, near 383.5 g/mol, so the stated formula and mass also tell you which form a report describes. The masses above are calculated from the formulas on the listings; the report for a specific lot is the authoritative record.
Why a very short peptide is harder to read than it looks
- Few couplings, few deletion products. Two coupling steps leave little room for synthesis failures, so purity figures for a tripeptide are typically high. A low figure is informative rather than routine; the same inversion is described in Epitalon: four residues and the limits of a short synthesis.
- Retention near the solvent front. A small, polar, basic molecule is weakly retained on a reversed-phase column and can elute close to the solvent front, where salts and system peaks also appear. The chromatogram should show the main peak clearly separated from that region, with its retention time stated.
- No aromatic residues in either compound. Neither KPV nor BPC-157 absorbs strongly above about 230 nm, so both are detected through the peptide bond near 210 to 220 nm. The detection wavelength belongs on the report.
- Counterions weigh more, relatively, on a small molecule. Lyophilized peptides are usually supplied as a salt. On a 342 g/mol molecule with two basic sites, the counterion can be a substantial share of the weighed solid, which is why the measured net content matters as much as the purity figure. See net peptide content.
- BPC-157's own signature is different. Its four prolines make deletion sequences the expected impurity, and its adjacent aspartates can rearrange into a species of identical mass, so its chromatogram and identity result have to be read together.
What each certificate of analysis must show
| Report section | For a KPV lot | For a BPC-157 lot |
|---|---|---|
| Identity | Observed mass in agreement with 342.4 g/mol (monoisotopic near 342.2), with the ion and its charge stated, or HPLC-RTM against a named KPV reference standard; the formula should say whether the free or the capped form is meant | Observed mass in agreement with 1,419.5 g/mol (monoisotopic near 1,418.7) within tolerance, or HPLC-RTM against a named BPC-157 reference standard |
| Chromatographic purity | Main-peak area as a percentage of total integrated area, with the chromatogram published; the main peak should sit clear of the solvent front | The same figure and trace; near-eluting deletion peaks are the expected signature |
| Net content | Measured mg of peptide in the vial, stated next to the labeled strength | Measured mg of peptide in the vial, stated next to the labeled strength |
| Endotoxin | Where tested: the method (LAL, with the USP <85> reference if claimed), the result with its units (EU per mL, per mg or per vial), and the limit it was compared against. | |
| Heavy metals | Where tested: the elements in the panel, the method, and a result or "none detected" against a stated reporting limit. | |
| Method fields | Column, mobile phase or gradient, detection wavelength, and reporting limit. A percentage with no method attached is not a result. | |
| Record fields | Material name, labeled strength, lot identifier matching the vial label, test date, certificate or accession number, and the issuing laboratory with its verification route. | |
Endotoxin and heavy-metal screens are only part of a report when the laboratory ran them. If a line is not on the certificate, that test was not performed on that lot; it has not been passed. The endotoxin testing guide explains what a LAL result and a USP <85> pass mean, and net peptide content explains why the measured mg can differ from the label.
How to tell them apart on paper
- Find the stated mass. Near 342 is KPV (near 383 if capped at both ends); near 1,419 is BPC-157. There is no overlap.
- Count the residues if a sequence is printed. Three against fifteen.
- Read the ion list. A KPV report shows ions near m/z 343 and 172; a BPC-157 report shows ions near 1,419.7 and 710.4.
- Check that the identity line names its reference. A retention-time result is only meaningful against a named standard for the same compound.
How to read our reports for these two
Our current reports come from three laboratories. Freedom Diagnostics reports give purity by HPLC-UV, identity by LC-MS, net content in mg, and an endotoxin result where one is listed; each carries an accession number and a search code for the laboratory's lookup page. ILS Laboratories reports give purity by HPLC, identity by retention-time match against a reference standard, net peptide content, and the screens run on that lot. Janoshik Analytical reports carry the laboratory's own verification key. Verify a lab report walks through each lookup.
- BPC-157 10mg: lot BP-2501A, 99.27% by HPLC-UV, identity confirmed by LC-MS, net content 10.21 mg, endotoxin pass (LAL, USP <85>, 2 replicates), reported Oct 15, 2026 by Freedom Diagnostics, accession 2610140677.
- BPC-157 5mg: lot BCP-2502-B, 99.59% by HPLC, identity confirmed, net peptide content 5.27 mg, fentanyl screen not detected, endotoxin ≤ 0.05 EU/mL, sterility no growth, heavy metals none detected, tested Aug 25, 2026 by ILS Laboratories, certificate COA-2026-Q53ZYU.
- KPV 10mg: listed in November 2026. Each lot is third-party tested, and the report is posted on the product page and in the COA library when it is back. As of this page's date (November 10, 2026) no KPV 10mg report is published yet.
- KLOW 80mg blend: the Freedom Diagnostics report for lot GW-2501A lists KPV as one component with its own measured net content (9.57 mg), alongside GHK-Cu, TB-500 and BPC-157 (7.69 mg). It is a blend record and does not describe a KPV 10mg lot.
Common questions
How do KPV and BPC-157 differ on a certificate of analysis?
KPV is the tripeptide Lys-Pro-Val, C16H30N4O4, 342.4 g/mol. BPC-157 is a 15-residue peptide, C62H98N16O22, 1,419.5 g/mol. The stated mass, the residue count and the ions in the mass-spectrometry section are all different, so a report for one cannot describe the other.
What mass should each report state?
KPV: about 342.2 (monoisotopic) or 342.4 g/mol (average), seen near m/z 343.2 as [M+H]+. BPC-157: about 1,418.7 (monoisotopic) or 1,419.5 g/mol (average), near m/z 1,419.7 and 710.4. A capped (N-acetyl, C-amide) KPV would sit near 383.5 g/mol.
Why does a high purity figure say less for KPV than for a longer peptide?
A three-residue chain has only two coupling steps, so few synthesis impurities are possible and high figures are typical. The more useful checks are that the main peak is well separated from the solvent front, that the detection wavelength is stated, and that net content is reported.
Which KPV and BPC-157 lots are documented on this site?
BPC-157 10mg lot BP-2501A (Freedom Diagnostics, 99.27%, Oct 15, 2026) and BPC-157 5mg lot BCP-2502-B (ILS Laboratories, 99.59%, Aug 25, 2026) have published reports. KPV 10mg was listed in November 2026; its lot report is posted on the product page and in the COA library when it is back.